(Q44872610)

7 December 2017

Improved survival related to changes in endometrial cancer treatment, a 30-year population based perspective (English)

1 reference

7 December 2017

1 reference

1

Jone Trovik

1 reference

7 December 2017

6

Helga B Salvesen

1 reference

7 December 2017

Karen K Mauland

2

1 reference

7 December 2017

Henrica M J Werner

series ordinal

3

1 reference

7 December 2017

Elisabeth Wik

series ordinal

4

1 reference

7 December 2017

Harald Helland

series ordinal

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 February 2012

1 reference

7 December 2017

1 reference

7 December 2017

125

1 reference

7 December 2017

381-387

1 reference

7 December 2017

2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

7 December 2017

1 reference

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Prognostic significance of DNA ploidy in stage I endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Influence of body mass index on prognosis in gynecological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Is body mass index an independent risk factor of survival among patients with endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

What is the role of chemotherapy in endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Body size, adult BMI gain and endometrial cancer risk: the multiethnic cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Body mass and risk of complications after hysterectomy on benign indications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Body size in relation to cancer of the uterine corpus in 1 million Norwegian women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Poorer survival of nulliparous women with endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

The effect of nulliparity on survival in endometrial cancer at different ages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Parity and time interval since childbirth influence survival in endometrial cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

What should lymphadenectomy offer in early-stage endometrial cancer: lots of variables, little control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.050

10.1016/J.YGYNO.2012.01.050

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference